Characteristic | All participants (N = 250) | Asymptomatic carriers (N = 32) | Non-carriers (N = 218) | P value |
---|---|---|---|---|
Mean (SD) age (years) | 66.9 (11.9) | 64.3 (12.1) | 67.2 (11.8) | 0.19 |
Median (IQR) days from admission to culture | 9 (4, 15) | 11.5 (6, 20.5) | 8 (4, 14) | 0.07 |
Days from admission to culture | ||||
0–7 | 110 | 13 (41) | 97 (44) | 0.34 |
8–14 | 75 | 7 (22) | 68 (31) | |
15–21 | 27 | 4 (12) | 23 (11) | |
≥22 | 38 | 8 (25) | 30 (14) | |
CDI in the previous 90 days | 13 | 6 (19) | 7 (3) | <0.001 |
Antibiotics in the past 90 days | 155 | 27 (84) | 128 (59) | 0.005 |
Antibiotics in the past 30 days | 144 | 24 (75) | 120 (55) | 0.03 |
Current antibiotic treatment | 98 | 12 (38) | 86 (39) | 0.83 |
Comorbidities | ||||
Heart disease | 95 | 9 (28) | 86 (39) | 0.22 |
Cancer | 85 | 12 (37) | 73 (33) | 0.65 |
Diabetes | 103 | 11 (34) | 92 (42) | 0.40 |
End stage renal disease | 23 | 3 (9) | 20 (9) | 0.97 |
Major surgery | 70 | 8 (25) | 62 (28) | 0.69 |
Spinal cord injury | 21 | 4 (13) | 17 (8) | 0.32 |